Results 231 to 240 of about 136,887 (323)

1‐Year Clinical Outcome Post‐Myasthenic Crisis: A Multicenter Prospective Study in China

open access: yesEuropean Journal of Neurology, Volume 33, Issue 2, February 2026.
In this prospective cohort of 282 patients with myasthenic crisis (MC) episodes, all‐cause mortality was 15.16%. Among 247 patients who have completed 1‐year follow‐up, 79.76% achieved favorable outcomes with significant improvement in the MG‐activities of daily living (MG‐ADL) score.
Xiao Huan   +38 more
wiley   +1 more source

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 196-215, February 2026.
Abstract Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders.
Anna Linda Zignego   +7 more
wiley   +1 more source

Idiopathic “myocarditis”?

open access: yesJournal of the American College of Cardiology, 1984
openaire   +2 more sources

Long‐term risk of cardiovascular events after COVID‐19 in the Swedish adult population—A matched cohort study

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 241-254, February 2026.
Abstract Background The long‐term risk across severity strata of people infected with SARS‐CoV‐2 has not yet been comprehensively described. Methods Using nationwide registries, all COVID‐19 cases in Sweden with <2 vaccine doses, with and without initial hospitalization (February 1, 2020 to June 30, 2022), were identified and matched with non‐COVID ...
Martin Lindgren   +10 more
wiley   +1 more source

Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis. [PDF]

open access: yesTheranostics
Hua X   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy